Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tamar Peretz-Yablonsky"'
Autor:
Heba Alkhatib, Jason Conage-Pough, Sangita Roy Chowdhury, Denen Shian, Deema Zaid, Ariel M. Rubinstein, Amir Sonnenblick, Tamar Peretz-Yablonsky, Avital Granit, Einat Carmon, Ishwar N. Kohale, Judy C. Boughey, Matthew P. Goetz, Liewei Wang, Forest M. White, Nataly Kravchenko-Balasha
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-7 (2024)
Abstract Triple negative breast cancer (TNBC) is a heterogeneous group of tumors which lack estrogen receptor, progesterone receptor, and HER2 expression. Targeted therapies have limited success in treating TNBC, thus a strategy enabling effective ta
Externí odkaz:
https://doaj.org/article/6e9c5a225b574c2e9c271b3e30c7bf17
Autor:
Heba Alkhatib, Ariel M. Rubinstein, Swetha Vasudevan, Efrat Flashner-Abramson, Shira Stefansky, Sangita Roy Chowdhury, Solomon Oguche, Tamar Peretz-Yablonsky, Avital Granit, Zvi Granot, Ittai Ben-Porath, Kim Sheva, Jon Feldman, Noa E. Cohen, Amichay Meirovitz, Nataly Kravchenko-Balasha
Publikováno v:
Genome Medicine, Vol 14, Iss 1, Pp 1-17 (2022)
Abstract Background Drug resistance continues to be a major limiting factor across diverse anti-cancer therapies. Contributing to the complexity of this challenge is cancer plasticity, in which one cancer subtype switches to another in response to tr
Externí odkaz:
https://doaj.org/article/1bfb8d0fe62b40729734ee0a48f29698
Autor:
Avital Granit, Kumudesh Mishra, Dinorah Barasch, Tamar Peretz-Yablonsky, Sara Eyal, Or Kakhlon
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Cisplatin is an effective chemotherapeutic agent for treating triple negative breast cancer (TNBC). Nevertheless, cisplatin-resistance might develop during the course of treatment, allegedly by metabolic reprograming, which might influence epigenetic
Externí odkaz:
https://doaj.org/article/58963cd8425e4136b4a995fe953342f3
Autor:
Heba Alkhatib, Solomon Oguche, Efrat Flashner-Abramson, Kim Sheva, Amichay Meirovitz, Z. Granot, Swetha Vasudevan, Shira Stefansky, Nataly Kravchenko-Balasha, Tamar Peretz-Yablonsky, Avital Granit, Ittai Ben-Porath, Ariel Rubinstein
SummaryTriple negative breast cancer (TNBC) is an aggressive type of cancer that is known to be resistant to radiotherapy (RT). Evidence is accumulating that is indicative of the plasticity of TNBC, where one cancer subtype switches to another in res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc219cdd23c4c10be2c8759ccdf7e25a
https://doi.org/10.1101/2021.01.07.425553
https://doi.org/10.1101/2021.01.07.425553
